ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis - Clamp, A; McNeish, I; Dean, A; Gallardo, D; Weon-Kim, J; O'Donnell, D; Hook, J; Coyle, C; Blagden, S; Brenton, J; Naik, R; Perren, T; et al. (Oxford University Press, 2017)